Valuation: Medpace Holdings, Inc.

Market Cap 15.92B 13.95B 12.85B 11.92B 22.64B 1,519B 22.95B 154B 59.84B 746B 59.8B 58.49B 2,585B P/E 2026 *
32.7x
P/E 2027 * 30x
Enterprise Value 14.76B 12.92B 11.9B 11.05B 20.98B 1,408B 21.26B 142B 55.45B 691B 55.41B 54.2B 2,395B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 4.85x
Free-Float
80.38%
Yield 2026 *
-
Yield 2027 * -
1 day+1.34%
1 week+5.68%
Current month+6.70%
1 month+23.41%
3 months+13.93%
6 months-7.19%
Current year+0.61%
1 week 523.69
Extreme 523.69
567.91
1 month 445
Extreme 445.005
567.91
Current year 373
Extreme 373
628.92
1 year 306.7
Extreme 306.7035
628.92
3 years 227.21
Extreme 227.21
628.92
5 years 126.94
Extreme 126.945
628.92
10 years 21.76
Extreme 21.76
628.92
Manager TitleAgeSince
Chief Executive Officer 69 1992-06-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 65 2017-08-31
Director TitleAgeSince
Chairman 69 1992-06-30
Director/Board Member 55 2016-06-30
Director/Board Member 72 2016-06-30
Date Insider Type Main position Quantity % Market Cap.
06-29Fiscal year

Director

72 0.0003%
06-29Fiscal year

Director

56 0.0002%
06-29Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.34%+5.68%+77.20%+141.51% 15.92B
+1.08%+8.57%+3.61%+9.34% 49.92B
+0.40%-1.37%+418.11%+625.15% 40.23B
-0.52%+6.57%+26.79%-5.37% 34.55B
+3.97%+6.71%+28.41%+63.36% 33.09B
-4.19%+6.03%+3.76%+32.17% 27.51B
-2.40%+1.60% - - 17.05B
-0.95%-0.38%+12.92%+17.96% 13.86B
+1.69%+3.09%+99.09%+99.19% 13.52B
-4.52%+52.54%+1,733.57%+733.76% 13.31B
Average -0.33%+11.12%+267.05%+190.79% 25.9B
Weighted average by Cap. +0.09%+9.17%+185.16%+173.71%

Financials

2026 *2027 *
Net sales 2.77B 2.43B 2.24B 2.08B 3.94B 265B 4B 26.79B 10.43B 130B 10.42B 10.19B 450B 2.95B 2.58B 2.38B 2.21B 4.19B 281B 4.25B 28.46B 11.07B 138B 11.07B 10.82B 478B
Net income 492M 431M 397M 369M 700M 46.96B 709M 4.75B 1.85B 23.05B 1.85B 1.81B 79.92B 539M 472M 435M 404M 767M 51.44B 777M 5.21B 2.03B 25.25B 2.03B 1.98B 87.54B
Net Debt -1.17B -1.02B -943M -875M -1.66B -112B -1.68B -11.29B -4.39B -54.73B -4.39B -4.29B -190B -1.62B -1.42B -1.31B -1.21B -2.3B -154B -2.33B -15.62B -6.08B -75.75B -6.08B -5.94B -263B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,300
Date Price Change Volume
26-07-06 US$565.09 +1.34% 234,156
26-07-02 US$557.60 +2.58% 356,575
26-07-01 US$543.57 +2.64% 312,635
26-06-30 US$529.59 -0.96% 335,554
26-06-29 US$534.72 +1.45% 390,789
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
557.60USD
Average target price
443.50USD
Spread / Average Target
-20.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock